New FDA Policy Takes Aim At Big Compounders

By Jeff Overley · March 23, 2018, 7:13 PM EDT

The U.S. Food and Drug Administration on Friday moved to limit the operations of large drug compounders, laying out policies that could dramatically curb their ability to sell cheaper versions of...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login